Witman, Nevin
Zhou, Chikai
Häneke, Timm
Xiao, Yao
Huang, Xiaoting
Rohner, Eduarde http://orcid.org/0000-0001-8411-3720
Sohlmér, Jesper http://orcid.org/0000-0003-2607-7500
Grote Beverborg, Niels http://orcid.org/0000-0003-4629-9960
Lehtinen, Miia L.
Chien, Kenneth R. http://orcid.org/0000-0002-2759-8378
Sahara, Makoto http://orcid.org/0000-0002-6281-5454
Funding for this research was provided by:
Vetenskapsrådet (2019-01359)
Hjärt-Lungfonden (20150421, 20190380)
Karolinska Institutet (Strategic Research Area Stem Cells and Regenerative Medicine 2020)
Article History
Received: 6 January 2023
Accepted: 30 August 2023
First Online: 5 September 2023
Change Date: 4 January 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-023-44507-1
Competing interests
: The authors declare the following competing interests that K.R.C. is a past co-founder of Moderna Therapeutics and is currently a member of the board of directors of eTheRNA. All other authors declare no competing interests.